Defining “platinum-ineligible” patients with metastatic urothelial cancer (mUC).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shilpa Gupta, Joaquim Bellmunt, Elizabeth R. Plimack, Guru P. Sonpavde, Petros Grivas, Andrea B. Apolo, Sumanta K. Pal, Arlene O. Siefker-Radtke, Thomas W. Flaig, Matt D. Galsky, Jonathan E. Rosenberg, Platinum-Ineligibility in Bladder Cancer Working Group
Institutions: Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard University, Fox Chase Cancer Center, Dana-Farber Cancer Institute, University of Washington, Fred Hutch Cancer Center, National Institutes of Health, National Cancer Institute, Center for Cancer Research, City Of Hope National Medical Center, City of Hope, The University of Texas MD Anderson Cancer Center, University of Colorado Cancer Center, Tisch Cancer Institute, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4286296197